2005Journal of Jianghan UniversityRequires access

Studies on the Antiprogesteronge and the Anti-glucocorticoid Activity of Mifepristone

Yali Ben

Open publisher page 0 citations

Abstract

Objective:To analyse the binding affinities to progesterone and glucocorticoid re-ceptorsof themifepristone. Methods:With radioligand binding assay, the receptor binding affinityof mifepristone to the rabbit uterus cytosol progesterone receptor and the rat liver glucocorticoid re-ceptor were measured. Results:Compared with progesterone, the relative binding affinity of mi-fepristone is396.67±25.32, and the 50% inhibitory concentration is (6.61±1.20) nmol/L; Comparedwith dexamethasone, the relative binding affinity of mifepristone is 344.41 ± 57.41, and the 50%inhibitory concentration is ( 4.21±1.02) n mol/L. Conclusion:Mifepristone, as a strong agent ofantiprogestin, can block progesterone and glucocorticoid activitiesand the anti-glucocorticoid effectof mifepristone should be noticed enough in the clinical use of this drug.

About this research paper

What this paper is about

Objective:To analyse the binding affinities to progesterone and glucocorticoid re-ceptorsof themifepristone. Methods:With radioligand binding assay, the receptor binding affinityof mifepristone to the rabbit uterus cytosol progesterone receptor and the rat liver glucocorticoid re-ceptor were measured. Results:Compared with progesterone, the relative binding affinity of mi-fepristone is396.67±25.32, and the 50% inhibitory concentration is (6.61±1.20) nmol/L; Comparedwith dexamethasone, the relative binding affinity of mifepristone is 344.41 ± 57.41, and the 50%inhibitory concentration is ( 4.21±1.02) n mol/L. Conclusion:Mifepristone, as a strong agent ofantiprogestin, can block progesterone and glucocorticoid activitiesand the anti-glucocorticoid effectof mifepristone should be noticed enough in the clinical use of this drug.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To analyse the binding affinities to progesterone and glucocorticoid re-ceptorsof themifepristone. Methods:With radioligand binding assay, the receptor binding affinityof mifepristone to the rabbit uterus cytosol progesterone receptor and the rat liver glucocorticoid re-ceptor were measured. Results:Compared with progesterone, the relative binding affinity of mi-fepristone is396.67±25.32, and the 50% inhibitory concentration is (6.61±1.20) nmol/L; Comparedwith dexamethasone, the relative binding affinity of mifepristone is 344.41 ± 57.41, and the 50%inhibitory concentration is ( 4.21±1.02) n mol/L. Conclusion:Mifepristone, as a strong agent ofantiprogestin, can block progesterone and glucocorticoid activitiesand the anti-glucocorticoid effectof mifepristone should be noticed enough in the clinical use of this drug.

Key concepts: Mifepristone, Glucocorticoid, Glucocorticoid receptor, Antiglucocorticoid, Progesterone receptor, Endocrinology, Internal medicine, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on the Antiprogesteronge and the Anti-glucocorticoid Activity of Mifepristone — Research Paper | ScholarLens